William J. Chapin

Also affiliated with Penn Center for AIDS Research, University of Pennsylvania Health System, Abramson Cancer Center, University of Pennsylvania

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Comparative effectiveness of sorafenib, lenvatinib, and nivolumab as first-line systemic therapy for patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis treated at VA Medical Centers.”.

Comparative effectiveness of sorafenib, lenvatinib, and nivolumab as first-line systemic therapy for patients with advanced hepatocellular carcinoma and Child-Pugh class B cirrhosis treated at VA Medical Centers.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4102

N/A

0DataRank · unranked

2 citations

Wei-Ting Hwang, Thomas B. Karasic, Anne Marie McCarthy, David E. Kaplan, William J. Chapin

Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis

Cancer Medicine(2022)10.1002/cam4.4906

N/A

0DataRank · unranked

25 citations

Wei‐Ting Hwang, Thomas B. Karasic, Anne Marie McCarthy, David E. Kaplan, William J. Chapin